[DOI] [PMC free article] [PubMed] [Google Scholar] 52.Vasamsetti SB, Karnewar S, Kanugula AK, Thatipalli AR, Kumar JM, Kotamraju S
It shows steady, safe progress over time, not rapid or unsafe drops
Current evidence suggests GLP-1 receptor activation in the brain contributes to reduced food intake, altered food preferences, improved glycemic control, and potentially neuroprotective effects
However, like semaglutide, retatrutide's effect on stomach emptying lessens over time, which might need a break from the drug to restore its effectiveness
Dual-action GLP-1/GIP receptor agonists like Zepbound can also mimic the action of GIP, a hormone that helps regulate blood sugar levels and metabolism
I have seen too many people use GLP-1 based compounds as an excuse to barely eat